Cut through the noise, find the signal: Intelligence for serious healthcare leaders
Analysis updated November 9, 2026
ASPIRE's design reveals a deliberate strategic choice by CMMI to extend total-cost-of-care accountability into Medicaid pediatrics — a population segment that has historically sat outside value-based care architecture. The model's 10-year runway and five-state cap signal that CMMI views this as a long-horizon infrastructure build, not a rapid-cycle test. That timeline is meaningful: it creates protected operational space for states and accountable entities to absorb early investment losses before reconciliation mechanisms deliver financial return.
The "high-risk / rising-risk" dual-track population definition is the model's most consequential architectural choice. High-risk children (confirmed complex medical and/or behavioral conditions) and rising-risk children (one or more risk factors) create two materially different actuarial profiles under the same payment framework. Rising-risk enrollment is where the model's population health logic lives — early identification prevents downstream cost accumulation — but it also creates adverse selection exposure if accountable entities are insufficiently sophisticated to identify and stratify these children before they become high-cost. States that cannot build that identification infrastructure during the pre-implementation phase will face persistent actuarial misalignment.
The cooperative agreement funding mechanism (rather than a direct payment model) means CMS is explicitly purchasing state capability-building, not just performance. This has a downstream implication: states that receive cooperative agreement funds and then underperform face reputational and programmatic risk, but not the same financial clawback exposure that a pure shared savings/shared risk model would impose. That is a more forgiving structure than most CMMI adult models, which reflects the political reality that pediatric Medicaid is difficult territory for aggressive downside risk.
The requirement that accountable entities — managed care plans or ACOs — partner with providers having specialized pediatric complex-care experience creates a credentialing bottleneck. In most states, the supply of providers with genuine expertise in co-occurring medical/behavioral pediatric complexity is thin. This constraint will function as a de facto barrier to entry for generic managed care organizations attempting to stand up ASPIRE participation without pre-existing pediatric specialty networks.
The NOFO (Notice of Funding Opportunity) has not yet been released as of this analysis. That means dollar amounts for cooperative agreement awards, per-member payment structures, quality measure specifications, and performance benchmarks are not yet public. Stakeholders should treat all financial modeling below as scenario-framing, not projection.
Without published cooperative agreement award amounts or per-member payment rates, precise break-even modeling is not possible from available source material. However, the structural contours of financial viability are clear.
Infrastructure investment threshold: States and accountable entities will need to fund care coordination infrastructure — care managers, integrated care plans, family support navigators, telehealth capacity (as illustrated by the same-day telehealth assessment in the ASPIRE journey map), and cross-provider data sharing — before any per-member payment or cooperative agreement reimbursement flows. For a state-level implementation across even a modest attributed population of 10,000–25,000 children, dedicated care coordination infrastructure at a ratio of 1 FTE per 100–150 complex pediatric patients implies 67–250 FTE care managers, at loaded costs of $75,000–$110,000 per FTE annually. That represents a $5M–$27.5M annual staffing investment before model revenue is established.
Offset logic: The journey map's explicit "avoids emergency department and inpatient psychiatric hospitalization" outcome for Elijah illustrates ASPIRE's cost displacement theory. A single avoided pediatric inpatient psychiatric admission represents $8,000–$25,000 in avoided acute cost depending on length of stay and geography. A single avoided ED visit with subsequent inpatient admission represents $3,000–$15,000. If accountable entities capture even partial shared savings on these avoidances across a population of several thousand attributed children, the math can eventually close — but the lag between infrastructure investment and actuarially measurable savings is likely 18–36 months minimum.
Revenue scenario framing:
Advantaged organizations: Medicaid managed care plans with existing pediatric specialty contracts and embedded care management infrastructure hold the strongest entry position. They already own the actuarial data, the provider relationships, and the administrative infrastructure to stand up an accountable entity. Plans operating in states with established pediatric complex care programs — children's hospital-anchored medical homes, existing care coordination waiver programs — can convert existing infrastructure into ASPIRE compliance at marginal cost.
Children's hospital systems are the hidden strategic winners here. Their specialized provider networks are explicitly what the model requires accountable entities to access. Children's hospitals that position themselves as the essential specialized provider partner — rather than attempting to serve as the accountable entity itself — can secure preferential network inclusion terms and potentially influence the quality measure specifications that flow through the NOFO.
Disadvantaged organizations: General adult-focused ACOs and health systems without established pediatric behavioral health capacity face significant build costs with no guarantee of selection among the five state slots. Investing in ASPIRE readiness without selection is a stranded cost.
Market consolidation implication: The five-state cap creates a winner-take-all dynamic at the state level. States selected will see accelerated consolidation among Medicaid managed care plans and pediatric specialty providers as accountable entity partnerships form. States not selected will have no ASPIRE activity, full stop. This creates a geographic bifurcation in pediatric value-based care market development that will persist for a decade.
Interaction with InCK Model: CMS explicitly references the Integrated Care for Kids (InCK) Model on the ASPIRE page as a related program. Organizations that participated in InCK should assess whether their operational learnings and existing care coordination infrastructure translate to ASPIRE eligibility — this is the clearest pathway to accelerated readiness.
Physician perspective: Pediatricians and child psychiatrists operating in an ASPIRE-participating state will experience increased administrative accountability — care plan documentation requirements, cross-provider communication obligations, and outcome tracking — without a clear fee schedule increase from the model itself. The benefit is care coordination infrastructure they currently fund out-of-pocket in time and effort: the journey map's "single comprehensive care plan shared with all providers" and proactive tracking across school and home environments represent genuine operational relief. Physicians who view care coordination as a burden they are currently absorbing unfunded should view ASPIRE infrastructure as a compensatory offset.
Health system perspective: Integrated health systems with pediatric service lines should evaluate whether positioning as an accountable entity or as a specialized provider partner better serves their strategic interest. Accountable entity status requires assuming cost accountability; specialized provider partner status secures preferred network inclusion without financial risk exposure. Systems with thin margins in pediatric behavioral health — which describes most health systems — should lean toward the partner model unless their actuarial confidence in the target population is high.
Hospital perspective: ASPIRE's explicit goal of keeping children in "least restrictive settings" is a direct utilization reduction signal for inpatient psychiatric beds. Children's hospitals and general hospitals with pediatric psychiatric units should model a 10–15% reduction in pediatric inpatient psychiatric volume in ASPIRE-participating states as a baseline planning assumption. This is not hypothetical: the Elijah journey map states as an explicit outcome that he "avoids inpatient psychiatric hospitalization." Hospitals should simultaneously position their care coordination and ambulatory intensive services as the infrastructure that makes that avoidance possible — converting potential volume loss into cooperative agreement-funded service delivery.
Payer/MA plan perspective: Medicare Advantage plans have no direct stake in ASPIRE (this is a Medicaid/CHIP model). However, Medicaid managed care plans with commercial or MA affiliates should note that ASPIRE's care coordination infrastructure — if effective — compresses the health trajectory of children who will eventually age into commercial and Medicare coverage. The long-term actuarial benefit to affiliated plan lines from healthier adult cohorts is real but difficult to monetize within a 10-year model window. The immediate priority for Medicaid MCOs is securing accountable entity status in selected states before the NOFO closes.
Analysis current as of ASPIRE Announced stage. VE will update upon NOFO release with specific award amounts, benchmark methodology, quality measure specifications, and application timeline. Contact ASPIREModel@cms.hhs.gov for direct model inquiries.